A Peer-reviewed,
open access bimonthly journal
pISSN 2092-7355   eISSN 2092-7363
    Allergy Asthma Immunol Res. 2011 Jul;3(3):157-167. English.
    Published online May 20, 2011.
    https://doi.org/10.4168/aair.2011.3.3.157
    Copyright © 2011 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease
    Review

    Occupational Asthma: Etiologies and Risk Factors

    Olivier Vandenplas
      • Department of Chest Medicine, Mont-Godinne Hospital, Université Catholique de Louvain, Yvoir, Belgium.
    • Correspondence to: Olivier Vandenplas, MD, PhD, Department of Chest Medicine, Mont-Godinne Hospital, Avenue Gaston Therasse 1, B-5530 Yvoir, Belgium. Tel: +32-81-42-33-63; Fax: +32-81-42-33-52; Email: olivier.vandenplas@uclouvain.be
    Received March 23, 2011; Accepted April 19, 2011.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Abstract

    The purpose of this article is to critically review the available evidence pertaining to occupational, environmental, and individual factors that can affect the development of occupational asthma (OA). Increasing evidence suggests that exploration of the intrinsic characteristics of OA-causing agents and associated structure-activity relationships offers promising avenues for quantifying the sensitizing potential of agents that are introduced in the workplace. The intensity of exposure to sensitizing agents has been identified as the most important environmental risk factor for OA and should remain the cornerstone for primary prevention strategies. The role of other environmental co-factors (e.g., non-respiratory routes of exposure and concomitant exposure to cigarette smoke and other pollutants) remains to be further delineated. There is convincing evidence that atopy is an important individual risk factor for OA induced by high-molecular-weight agents. There is some evidence that genetic factors, such as leukocyte antigen class II alleles, are associated with an increased risk of OA; however, the role of genetic susceptibility factors is likely to be obscured by complex gene-environment interactions. OA, as well as asthma in general, is a complex disease that results from multiple interactions between environmental factors and host susceptibilities. Determining these interactions is a crucial step towards implementing optimal prevention policies.

    Keywords
    Allergy; asthma; occupational disease

    INTRODUCTION

    It is now generally accepted that the workplace environment can lead to the development of different types of work-related asthma, including occupational asthma (OA) (i.e., asthma caused being at work) and work-exacerbated asthma (i.e., pre-existing or coincident asthma exacerbated by non-specific stimuli at work).1, 2 OA may result from either immunologically-mediated sensitization to occupational agents (i.e., 'allergic' occupational asthma or 'occupational asthma with a latency period') or from exposure(s) to high concentrations of irritant compounds (i.e., 'irritant-induced asthma'), which is best typified by 'reactive airways dysfunction syndrome'.1, 2 In recent years, there has been a growing recognition that work-related asthma represents a significant public health concern because of its high prevalence (~15% of adult asthma)3 and substantial health and socio-economic impacts.4 OA is potentially preventable, by effective control of respiratory sensitizers in the workplace. Accordingly, identifying causal agents and associated risk factors is a key step towards optimal prevention of the disease. This review aims at summarizing our current understanding of the factors that determine the inception of 'allergic' OA.

    ETIOLOGICAL AGENTS

    Workplace agents that are known to cause allergic OA include high-molecular-weight (HMW) (glyco)-proteins from vegetal and animal origins and low-molecular-weight (LMW) compounds. HMW proteins and a few LMW compounds (e.g., platinum salts, reactive dyes, acid anhydrides, sulfonechloramide, and some wood species) act through a documented IgE-mediated mechanism.5, 6 The immunological mechanisms underlying the effects of most LMW agents (e.g., isocyanates, persulphate salts, aldehydes, and wood dusts) have not been fully characterized.

    Sensitizing potential

    Identifying characteristics associated with the induction of airway sensitization is fundamental to the implementation of primary preventive strategies. Research performed over recent years has highlighted the possible role of inherent protease activity, surface features, and glycosylation patterns of HMW allergens in the initiation of Th2 and IgE antibody responses.7 There is growing evidence that allergens possess common molecular features that enable them to be recognized by innate immune defenses as Th2-inducing antigens. For example, recent data suggest that allergens with lipid-binding properties, such as the major house dust mite allergen Der p2, have intrinsic adjuvant activity and can interact with the Toll-like receptor 4 signaling pathway.8 These events could be further amplified by proteolytically active allergens through the digestion of cell surface molecules involved in regulating innate and adaptive immune function, thereby favoring Th2 responses. These data support the observation that enzymes are a common cause of OA in a wide variety of occupations.9 Resistance to degradation may also be important for some occupational HMW allergens, which may be altered by physical or chemical agents during industrial or manufacturing processes. This is best illustrated by the persistence of allergenic epitopes derived from the Hevea braziliensis tree in natural rubber latex, despite treatment with ammonia and vulcanization at high temperature.

    In contrast to protein allergens, LMW agents are incomplete antigens (i.e., haptens) that must first bind to carrier macromolecules to become immunogenic. It has long been recognized that OA-causing LMW agents are typically highly reactive electrophilic compounds that are capable of combining with the hydroxyl, amino, and thiol functionalities on airway proteins.6, 10, 11

    LMW sensitizing agents also include transition metals salts, where the asthmagenic mechanism is thought to involve coordination bonding with human proteins.12 Quantitative structure-activity relationship (QSAR) models have been developed for the prospective identification of potentially sensitizing chemicals.13 Comparisons of the chemical substructures present in LMW organic asthmagens and non-sensitizing chemicals have identified several reactive groups that are associated with a high risk of respiratory sensitization, such as isocyanate (N=C=O), carbonyl (C=O), and amine (NH2), particularly when two or more groups are present within the same molecule.14 These multiple reactive groups could react simultaneously with different amino acids present on native human proteins, leading to intra-molecular cross-linking, conformational changes, and the production of neo-epitopes within the protein molecules. Such neo-epitopes could be involved in the initiation of respiratory sensitization.

    Causal agents

    A large number of substances used in the workplace can lead to the development of allergic OA. Updated lists of causal agents and occupations are available on the web (e.g., http://www.asthme.csst.qc.ca and http://www.asmanet.com). A quick search of PubMed through 2009 and a personal bibliography for articles published before 1976 identified about 360 compounds or processes that have been described as causing OA, with a mean of 12 new causal agents reported annually since 1990. However, data derived from voluntary notification programs and compensation statistics of OA in various countries show that only a few agents (flour, isocyanates, latex, persulphate salts, aldehydes, animals, wood dusts, metals, enzymes) account for 50-90% of reported cases (Table 1).15-23 Nevertheless, the distribution of causal agents may vary across geographical areas, depending upon the pattern of industrial activities. For example, a high rate of OA due to metal machining fluids (11% of all cases), adhesives (7%), and chrome (7%) has been reported in the West Midlands, an area in the UK with high manufacturing activity.24 In some countries, greenhouse cultivation is a growing activity that may lead to unusually high levels of exposure to airborne plant allergens that may induce occupational rhinitis and asthma in a substantial proportion of exposed workers.25 Additionally, greenhouse workers may become sensitized to pest insects, predatory mites used for the biological control of pests, molds, and latex gloves. In the southern part of Korea, the Tetranychidae mite Panonychus citri has been identified as a common cause of IgE-mediated respiratory allergies in citrus farmers.26

    Table 1
    Principal agents shown to cause occupational asthma in various countries

    There is currently little information on changes in the patterns of causal agents over time (Table 1).15-17 The number of cases of isocyanate-induced OA appears to have declined in some countries,16 likely due to the implementation of preventive measures. Available data also indicate that there has been a marked increase in the number of reported OA cases due to latex use during the 1990s. However, an analysis of the Belgian compensation data using the year of asthma onset, rather than the year of claim submission, showed that the incidence of latex-induced asthma decreased in the late 1990s, together with a sharp decline in the use of powdered latex gloves.27 Over the period from 1998 to 2002, the Finnish Register of Occupational Diseases documented a substantial increase in the rate of OA caused by sensitization to molds in white-collar workers employed in water-damaged buildings. This population accounted for up to 18% of notified cases in 1998-2002.15 During the same period, there was a downward trend in OA caused by cow dander, which resulted from a marked decrease in agricultural activities and changes in dairy farming practices.

    At-risk occupations

    Notification programs have generally reported the highest incidence rates of OA in bakers and pastry makers, other food processors, spray painters, hairdressers, wood workers, healthcare workers, cleaners, farmers, laboratory technicians, and welders.17, 18, 21 In fact, these occupations accounted for about two-thirds of all notified cases of OA, which may be relevant for targeting prevention and surveillance programs. In recent years, population-based studies conducted in various countries worldwide have consistently found that cleaning activities were associated with an excess risk of asthma, compared with unexposed individuals.28, 29 Additionally, the Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994) showed that cleaners were at an increased risk of experiencing work-related asthma symptoms (odds ratio [OR]: 2.4; 95% confidence interval [CI]: 0.5-10.6) and work-related wheezing (OR: 5.4; 95% CI: 2.4-12.2).30 Industrial and domestic cleaners use a wide variety of products containing irritant chemicals (e.g., detergents, acids, alkali, solvents, chelating compounds), as well as some potentially sensitizing substances, including biocides (e.g., chloramine-T, aldehydes, quaternary ammonium derivatives), ethanolamines, enzymes, and latex gloves. Additionally, cleaners are exposed to various workplace and domestic pollutants and allergens, such as endotoxins, house dust mites, pets, and molds. Different agents and mechanisms are presumably involved in the development of cleaning-related asthma and rhinitis. Recent studies found that a higher risk of asthma attacks31 and new-onset asthma32 was associated with exposure to bleach, ammonia, degreasing sprays, and accidental inhalation of vapors and gases from cleaning agents. These findings support an important role for acute and chronic exposure to irritants in inducing 'irritant-induced asthma' (e.g., 'reactive airways dysfunction syndrome') and 'work-exacerbated asthma.' Data collected by the Sentinel Event Notification System for Occupational Risks (SENSOR) in four US states from 1993 to 1997 showed that 12% of the reported cases of work-related asthma were associated with exposure to cleaning products.33 Among these cases, 20% were categorized as 'work-exacerbated asthma' and 80% as new-onset asthma, including 22% with probable 'reactive airways dysfunction syndrome' and the remainder with OA; however, the sensitizing agent was identified in only 14% of OA cases.

    ENVIRONMENTAL RISK FACTORS

    Environmental factors that are potentially involved in the initiation of OA include the level of exposure to sensitizing agents, the mode and route of exposure to these agents, and concomitant exposure to pollutants at the workplace.

    Level of exposure

    The assessment of dose-response relationships in OA has been greatly enhanced by the development of immunoassay techniques for the measurement of low concentrations of airborne HMW allergens in the workplace, the use of personal sampling techniques, and the implementation of prospective cohort studies.34 These studies have provided strong evidence supporting a dose-response relationship between the exposure level to occupational agents and the development of IgE-mediated sensitization and work-related respiratory symptoms for agents acting through an IgE-mediated mechanism (e.g., wheat flour, fungal alpha-amylase, laboratory animal proteins, detergent enzymes, snow crab allergens, platinum salts, acid anhydrides). An exposure-response gradient has been documented between the time-weighted average concentrations of isocyanates and the development of OA in a case-referent study.35 In a recent survey of spray painters, a log-linear relationship was found between the presence of specific IgE antibodies against isocyanate oligomers and the level of exposure and work-related symptoms.36 Specific IgG levels appeared to be merely an indicator of exposure.

    The determination of dose-response relationships may have a major effect on establishing permissible concentrations for prevention.37 However, uncertainties remain with respect to the relative importance of peak versus average levels of exposure, the risk of sensitization at low concentrations (i.e., the 'no-effect level'), and the shape of the dose-response curve.38 There is some evidence among laboratory animal workers that high-level exposures to laboratory animal allergens have a protective effect on the development of IgE-mediated sensitization and allergy symptoms.39, 40 These studies observed that a high level of exposure to rat and mouse allergens was associated with increased levels of specific IgG4 antibodies, higher ratios of specific IgG4/IgE antibodies, and a reduction in work-related symptoms. A large workforce cross-sectional study of bakery workers conducted in the Netherlands also documented a bell-shaped exposure-response relationship, especially for cumulative wheat allergen exposure with IgE sensitization, allergic respiratory symptoms, and asthma; however, the healthy worker effect (HWE) may have been a possible explanation for the bell-shaped relationship.41 These findings are suggestive of a high-dose immunological tolerance to allergens associated with a modified Th2 cell response, which has been described for cat allergens in children.42 However, the attenuation of sensitization at high-dose exposure levels has not been documented for other workplace allergens, such as flour and detergent enzymes, or even in other surveys of workers exposed to laboratory animals.43 The mechanisms through which certain allergens induce tolerance at high exposure levels, while others drive a linear exposure-response relationship remain unknown. The functional role of IgG4 antibodies in the protection of sensitization at high allergen exposure levels has not been formally demonstrated. On the other hand, a recent survey of Korean bakery workers suggests that wheat-specific IgG4 antibodies may play a role in the development of respiratory symptoms in exposed workers who lack wheat-specific IgE antibodies.44

    The interpretation of exposure-response relationships may be further complicated by the discordance between reported respiratory symptoms and documented IgE-mediated sensitization to occupational allergens.45 For example, among Korean bakers, only a low proportion (25%) of symptomatic workers showed positive wheat-specific IgE antibodies.44 Additionally, individual susceptibility factors may affect the exposure-response relationships. Genetic markers could also be stronger determinants of sensitization to occupational agents at low levels of exposure to occupational agents.46 However, in the cohort of Dutch bakers mentioned above, associations between exposure levels and the prevalence of sensitization to wheat allergens and clinical outcomes were found only in atopic individuals.41 The timing of exposure may also play a role because the onset of work-related asthma symptoms is consistently higher within the early period of exposure to the occupational agents.47-49 Exposure-response gradients are more clearly documented in those workers who develop these outcomes soon after the onset of exposure.48 These findings indicate that the level of exposure at critical time points may be more relevant to the development of OA than cumulative doses of exposure or current levels of exposure at the time of investigation.

    Mode of exposure

    Differences in the mode of exposure to the same HMW agent may result in different patterns of IgE responses. In asthma epidemics caused by soybean dust released during soybean unloading into harbor silos, citizens became sensitized to Gly m 1 and Gly m 2, which are proteins with a low molecular weight (7-8 kDa) that are concentrated in the hull. In contrast, bakers are predominantly sensitized to allergens with a higher molecular weight that are present in both the soybean hull and flour.50 It has also been reported that workers may develop specific airway reactivity directed against one, but not the other forms of LMW chemicals (e.g., vapors of isocyanate monomers versus aerosols of isocyanates prepolymers; formaldehyde resin dust versus gaseous formaldehyde).51, 52 The extent to which the physicochemical properties of LMW agents, such as volatility and solubility, may influence the patterns of airway deposition and the potential for inducing airway sensitization has not been extensively investigated. Recent experiments have shown that that the biophysics of exposure may have a strong influence on the formation of human protein conjugates with diisocyanates, which might affect the immunogenicity of the resulting conjugate.53, 54

    Animal experiments have consistently demonstrated that dermal exposure to LMW occupational agents can initiate IgE-mediated respiratory sensitization with a predominant Th2-like immune response, as well as the development of eosinophilic airway inflammation and airway hyperresponsiveness to these agents.55-57 The identification of type 1 keratins conjugated to hexamethylene diisocyanate after both skin and inhalation exposure offers potentially new insights into the link between skin sensitization to LMW chemicals and the induction of airway hyperresponsiveness to isocyanates in animal models.10 Much less is known regarding the potential impact of skin exposure on the initiation of OA in humans because the effects of dermal contact cannot readily be quantified or differentiated from those of inhalation exposure, as both occur simultaneously. Indirect evidence from a growing number of clinical and epidemiological studies in workplaces where measured airborne exposures to isocyanates were very low or non-detectable suggests that skin exposure to these reactive chemicals can contribute to an increase in the risk for sensitization and asthma.58

    Co-exposure to pollutants

    There is growing evidence that environmental pollutants, such as ozone, nitrogen dioxide, tobacco smoke, diesel exhaust particles, and endotoxin can act as adjuvants in allergic responses to common inhalant allergens.59 However, there is limited information on the potential interactions between pollutants and sensitizing agents in the workplace. Smoking has been documented as a significant risk factor for the development of sensitization to a number of occupational agents, such as animal allergens (e.g., laboratory animals, snow crab, prawn, salmon) and some LMW agents (e.g., platinum salts, acid anhydrides, reactive dyes).60 However, only a few studies have provided direct evidence that cigarette smoking can increase the risk of clinical allergy or OA.61-65

    Exposure to endotoxin, which are components of the outer membrane of gram-negative bacteria, occurs in many occupational settings.66 There is accumulating evidence that endotoxin may affect allergic sensitization to allergens, in addition to inducing asthma-like symptoms and airway neutrophilic inflammation. However, the effects of co-exposure to endotoxin and allergens remain uncertain. Endotoxin may either enhance or inhibit the allergic process, depending on the timing and dose of exposure, as well as the individual genetic background. Pacheco et al.67 showed that the ability to respond to airborne endotoxin through the Toll-like receptor 4 (TLR4) in conjunction with an allergen could affect the risk for sensitization to laboratory animals. In a survey of laboratory workers, they found that the TLR4/8551 G variant, which is less responsive to endotoxin, was significantly associated with atopy and sensitization to laboratory animals.

    INDIVIDUAL SUSCEPTIBILITY

    The observation that only a few workers typically develop OA despite similar workplace exposures strongly suggests that underlying differences in individual susceptibility exist. Host factors that have been incriminated in the development of OA include atopy, genetic factors, rhinitis, pre-existing non-specific airway hyperresponsiveness, and gender.

    Atopy

    Atopy, which is defined as an increased propensity to produce an IgE antibody response to low-dose environmental aeroallergens, can be established by assessing the presence of IgE antibodies against common inhalant allergens. Atopy has been consistently documented as a major risk factor for the development of IgE-mediated sensitization and OA in response to HMW agents that induce the production of specific IgE antibodies.68, 69 This association remains controversial for some LMW agents, such as acid anhydrides70, 71 and platinum salts72, 73. Nevertheless, the identification of atopy is not regarded as a reliable marker for excluding potentially susceptible workers from exposed jobs because it is a highly prevalent trait in the general population, and thus yields only a weak positive predictive value for sensitization to LMW agents and OA.69 Interestingly, studies suggest that atopy could be a stronger risk factor for laboratory animal sensitization among workers with low levels of exposure.47, 74 Furthermore, pre-exposure sensitization to common allergens that are structurally related to workplace allergens, such as pets in laboratory animal workers, could be a stronger predictor of OA than atopy.75, 76 In a 2-year prospective cohort study of workers beginning laboratory animal exposure, the combination of atopy and a total IgE level greater than 100 IU/mL was the best predictor for the development of laboratory animal allergies.77 Using these criteria may make it possible to reduce occupational sensitization by approximately 50% with less than 10% false-positive predictions. Interestingly, this cohort study found that baseline assessments of nasal inflammation parameters or cytokine production profiles did not predict the development of specific sensitization.77

    Genetic factors

    With current advances in human genetics, research has been directed towards investigating the genetic basis of individual susceptibility to OA development. Several studies have documented significant associations between OA due to various LMW and HMW occupational allergens (e.g., isocyanates, red cedar, acid anhydrides, platinum salts, natural rubber latex, laboratory animals) and HLA class II molecules, which are involved in the presentation of processed antigens to T-lymphocytes (Table 2).46, 78-86 Specific HLA DR, HLA-DQ, and HLA-DP alleles were found to confer either susceptibility or protection against OA; however, these findings have not always been replicated in other studies.87-89

    Table 2
    Genes involved in susceptibility to occupational asthma

    Possible role of genes associated with TH2-cell differentiation in the development of OA was suggested in one study that assessed the allelic variants of TH2-related cytokines, IL-4 receptor α chain (IL4RA) and IL-13, and one CD14 (C159T) gene polymorphism in isocyanate-induced OA.90 The IL-4RA (I50V) II genotype alone and in combination with IL-13 (R110Q) RR, and the CD14 (C159T) genotypes were significantly associated with OA caused by hexamethylene diisocyanate. Pacheco et al.67 evaluated whether allelic variants of TLR4, which is the predominant endotoxin-specific cell-surface receptor, could modulate allergic responses to laboratory animals. The TLR4/8551 G variant, which is less responsive to endotoxin, was significantly associated with an increased risk of sensitization to laboratory animals and other inhalant allergens.67 An investigation of isocyanate-induced innate immune responses found that subjects who lacked the major (type 1) human chitinase showed decreased serum concentrations of chitinase 3-like-1. In contrast, individuals possessing at least one functional chitinase-1 allele did not show this decrease.91 With respect to neurogenic inflammation, a Korean study found no association between genetic polymorphisms of the neurokinin 2 receptor (NK2R G231E, NK2R R375H) and isocyanate-induced OA. However, subjects with the GG genotype of NK2R G231E showed higher serum vascular endothelial growth factor (VEGF) levels than those with the GA or AA genotype, which may contribute to perpetuating airway inflammation.92

    Genes involved in protection against oxidative stress, such as glutathione-S-transferase (GSTP1 and GSTM1) and N-acetyltransferase (NAT), have been explored in isocyanate-induced OA.93-96 The GSTM1 null genotype was associated with an increased risk of isocyanate-induced OA,93 while the GSTP1*Val/Val allele conferred protection against the development of OA. This protective effect increased with the duration of toluene diisocyanate (TDI) exposure.95 Slow N-acetylator phenotypes were found to be at a higher risk for diisocyanate-induced asthma.94, 96

    A recent genome-wide association screening among Korean workers with OA caused by toluene diisocyanate found that several single-nucleotide polymorphisms of catenin alpha 3 (CTNNA3, coding for alpha T-catenin) and catenin alpha 1 (CTNNA1, encoding alpha E-catenin) were significantly associated with OA.97 Additionally, two genetic polymorphisms of CTNNA3 (rs10762058 and rs7088181) were significantly associated with a higher level of non-specific bronchial hyperresponsiveness. An additional polymorphism (rs1786929) was associated with higher levels of serum-specific IgG against cytokeratin 19. Alpha-catenin is a key molecule in the E-cadherin-mediated cell-cell adhesion complex. Further functional studies are needed to clarify the exact mechanisms by which CTNNA3 and CTNNA1 gene polymorphisms contribute to the development of isocyanate-induced OA.6

    Overall, the currently available information indicates that genetic testing is limited for both diagnostic and preventive purposes.98 It is unknown why one gene may represent a risk factor in some populations, but not in others. As an example, the HLADQB1*0501 allele is associated with an increased susceptibility for developing specific IgE antibodies against acid anhydrides,82 while the same allele is protective for diisocyanate- and plicatic acid-associated OA.80, 83 There is also convincing evidence that a wide variety of environmental factors can interact with genetic determinants to affect disease susceptibility. These observations highlight the importance of measuring environmental exposure in genetic studies of OA. Such environmental factors include viral infections, diet, exposure to endotoxin, tobacco smoke, and irritants, as well as the pattern and timing of exposure to sensitizers in the workplace. For example, a gene-environment interaction has been demonstrated for sensitization to platinum salts.46 In platinum refinery workers, the relative risk of sensitization associated with the HLA-DR3 phenotype was more apparent at lower levels of exposure. This finding indicates that the role of genetic susceptibility is likely to increase in workplace environments where exposure to sensitizers has been minimized.

    Non-specific bronchial hyperresponsiveness

    In recent years, prospective cohort studies of subjects entering a workplace with exposure to occupational sensitizers have provided formal evidence that baseline bronchial hyperresponsiveness and a physician-based diagnosis of asthma are associated with an increased risk of OA.76, 99

    Rhinitis

    Population-based and cohort studies provide compelling evidence that rhinitis (allergic and non-allergic) is a risk factor for the development of non-occupational asthma.100-102 Clinical studies have shown that the majority of workers with OA also suffer from occupational rhinitis. Of these patients, work-related rhinitis symptoms frequently precede the onset of OA, especially when HMW agents are involved.103 Epidemiological evidence shows that work-related rhinitis is associated with an increased risk for the subsequent development of asthma104 and OA49, 105, and should be considered as an early marker of OA.106 However, the proportion of subjects with work-related rhinitis who will go on to develop OA remains uncertain. Among apprentices in animal health technology, the predictive value of work-related nasal symptoms on the subsequent development of probable OA was only 11.4% over a 44-month follow-up period.49 Prospective cohort studies of apprentices have also shown that the presence of rhinitis prior to work exposure is an independent risk factor for IgE sensitization to HMW occupational allergens.99, 107

    Gender

    Disparities in the incidence of OA among men and women have usually been ascribed to gender-related differences in job distribution. For example, in surveys of workers exposed to snow crab allergens, the prevalence of probable OA in women was markedly higher than in men. However, it could not be excluded that this difference was a result of the over representation of women in job categories with high exposure.65, 108

    CONCLUSIONS

    Identifying the intrinsic characteristics of OA-causing agents that determine their sensitizing potential is important for preventing the introduction of hazardous substances in the workplace. A dose-response relationship between exposure levels and the development of immunological sensitization and OA has now been convincingly established for the most frequent agents that cause OA. As a result, preventive measures aimed at reducing workplace exposure to sensitizing agents should be the most effective approach for reducing the burden of OA. However, there is some suggestion that the exposure-response relationship may bell-shaped rather than linear for some occupational agents (e.g., laboratory animals, wheat flour), suggesting a protective effect of high-level exposures. Several studies indicate that exposure to cigarette smoke can increase the risk of IgE-mediated sensitization to some HMW and LMW agents; however, the evidence supporting an association between smoking and the development of clinical OA remains very weak. The role of other environmental co-factors, such as endotoxins and chemical pollutants, should be further investigated.

    Atopy has been consistently demonstrated as an important individual risk factor for the development of IgE sensitization and OA, but only for HMW agents. Identifying sub populations at higher risk within the atopic group would increase the feasibility of pre-employment screening and counseling. Prospective cohort studies of individuals entering a workplace with exposure to occupational sensitizing agents have shown that the presence of rhinitis and non-specific bronchial hyperesponsiveness at baseline are associated with an increased risk of IgE sensitization and OA. Associations between genetic markers and OA have usually been modest, but there is increasing evidence that gene-environment interactions can influence these exposure-response relationships. Characterizing the complex interactions between environmental factors and individual susceptibility is a crucial step in identifying the factors that determine the development of OA, and in implementing cost-effective prevention strategies.

    Notes

    There are no financial or other issues that might lead to conflict of interest.

    ACKNOWLEDGMENTS

    This work has been supported in part by a grant from the Action de recherche concertée (ARC) de la Communauté Française de Belgique.

    References

      1. Vandenplas O, Malo JL. Definitions and types of work-related asthma: a nosological approach. Eur Respir J 2003;21:706–712.
      1. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008;134:1S–41S.
      1. Torén K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med 2009;9:7.
      1. Vandenplas O. Socioeconomic impact of work-related asthma. Expert Rev Pharmacoecon Outcomes Res 2008;8:395–400.
      1. Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol 2009;123:531–542.
        quiz 43-4.
      1. Palikhe NS, Kim JH, Park HS. Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol Res 2011;3:21–26.
      1. Shakib F, Ghaemmaghami AM, Sewell HF. The molecular basis of allergenicity. Trends Immunol 2008;29:633–642.
      1. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, Karp CL. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009;457:585–588.
      1. Baur X. Enzymes as occupational and environmental respiratory sensitisers. Int Arch Occup Environ Health 2005;78:279–286.
      1. Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 2000;162:2330–2336.
      1. Choi JH, Nahm DH, Kim SH, Kim YS, Suh CH, Park HS, Ahn SW. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol 2004;93:293–298.
      1. Agius RM. Why are some low-molecular-weight agents asthmagenic. Occup Med 2000;15:369–384.
      1. Seed MJ, Cullinan P, Agius RM. Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr Opin Allergy Clin Immunol 2008;8:103–109.
      1. Jarvis J, Seed MJ, Elton R, Sawyer L, Agius R. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup Environ Med 2005;62:243–250.
      1. Piipari R, Keskinen H. Agents causing occupational asthma in Finland in 1986-2002: cow epithelium bypassed by moulds from moisture-damaged buildings. Clin Exp Allergy 2005;35:1632–1637.
      1. Malo JL, Chan-Yeung M. Occupational asthma. J Allergy Clin Immunol 2001;108:317–328.
      1. McDonald JC, Chen Y, Zekveld C, Cherry NM. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med 2005;62:836–842.
      1. Ameille J, Pauli G, Calastreng-Crinquand A, Vervloët D, Iwatsubo Y, Popin E, Bayeux-Dunglas MC, Kopferschmitt-Kubler MC. Reported incidence of occupational asthma in France, 1996-99: the ONAP programme. Occup Environ Med 2003;60:136–141.
      1. Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as identified by the Surveillance of Work-related and Occupational Respiratory Diseases programme in South Africa. Clin Exp Allergy 2001;31:32–39.
      1. Elder D, Abramson M, Fish D, Johnson A, McKenzie D, Sim M. Surveillance of Australian workplace Based Respiratory Events (SABRE): notifications for the first 3.5 years and validation of occupational asthma cases. Occup Med (Lond) 2004;54:395–399.
      1. Vandenplas O, Larbanois A, Bugli C, Kempeneers E, Nemery B. The epidemiology of occupational asthma in Belgium. Rev Mal Respir 2005;22:421–430.
      1. Orriols R, Costa R, Albanell M, Alberti C, Castejon J, Monso E, Panades R, Rubira N, Zock JP. Reported occupational respiratory diseases in Catalonia. Occup Environ Med 2006;63:255–260.
      1. Oh SS, Kim KS. Occupational asthma in Korea. J Korean Med Sci 2010;25:S20–S25.
      1. Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med (Lond) 2008;58:169–174.
      1. Monsó E, Magarolas R, Badorrey I, Radon K, Nowak D, Morera J. Occupational asthma in greenhouse flower and ornamental plant growers. Am J Respir Crit Care Med 2002;165:954–960.
      1. Kim YK, Son JW, Kim HY, Park HS, Lee MH, Cho SH, Min KU, Kim YY. Citrus red mite (Panonychus citri) is the most common sensitizing allergen of asthma and rhinitis in citrus farmers. Clin Exp Allergy 1999;29:1102–1109.
      1. Vandenplas O, Larbanois A, Vanassche F, François S, Jamart J, Vandeweerdt M, Thimpont J. Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy 2009;64:415–420.
      1. Kogevinas M, Antó JM, Sunyer J, Tobias A, Kromhout H, Burney P. European Community Respiratory Health Survey Study Group. Occupational asthma in Europe and other industrialised areas: a population-based study. Lancet 1999;353:1750–1754.
      1. Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Torén K, Alliksoo A, Benke G, Blanc PD, Dahlman-Hoglund A, D'Errico A, Héry M, Kennedy S, Kunzli N, Leynaert B, Mirabelli MC, Muniozguren N, Norbäck D, Olivieri M, Payo F, Villani S, van Sprundel M, Urrutia I, Wieslander G, Sunyer J, Antó JM. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007;370:336–341.
      1. Arif AA, Delclos GL, Whitehead LW, Tortolero SR, Lee ES. Occupational exposures associated with work-related asthma and work-related wheezing among U.S. workers. Am J Ind Med 2003;44:368–376.
      1. Medina-Ramón M, Zock JP, Kogevinas M, Sunyer J, Torralba Y, Borrell A, Burgos F, Antó JM. Asthma, chronic bronchitis, and exposure to irritant agents in occupational domestic cleaning: a nested case-control study. Occup Environ Med 2005;62:598–606.
      1. Mirabelli MC, Zock JP, Plana E, Antó JM, Benke G, Blanc PD, Dahlman-Höglund A, Jarvis DL, Kromhout H, Lillienberg L, Norbäck D, Olivieri M, Radon K, Sunyer J, Torén K, van Sprundel M, Villani S, Kogevinas M. Occupational risk factors for asthma among nurses and related healthcare professionals in an international study. Occup Environ Med 2007;64:474–479.
      1. Rosenman KD, Reilly MJ, Schill DP, Valiante D, Flattery J, Harrison R, Reinisch F, Pechter E, Davis L, Tumpowsky CM, Filios M. Cleaning products and work-related asthma. J Occup Environ Med 2003;45:556–563.
      1. Jones MG. Exposure-response in occupational allergy. Curr Opin Allergy Clin Immunol 2008;8:110–114.
      1. Meredith SK, Bugler J, Clark RL. Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 2000;57:830–836.
      1. Pronk A, Preller L, Raulf-Heimsoth M, Jonkers IC, Lammers JW, Wouters IM, Doekes G, Wisnewski AV, Heederik D. Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 2007;176:1090–1097.
      1. Baur X. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol 2003;90:11–18.
      1. Heederik D, Houba R. An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg 2001;45:175–185.
      1. Jeal H, Draper A, Harris J, Taylor AN, Cullinan P, Jones M. Modified Th2 responses at high-dose exposures to allergen: using an occupational model. Am J Respir Crit Care Med 2006;174:21–25.
      1. Matsui EC, Diette GB, Krop EJ, Aalberse RC, Smith AL, Eggleston PA. Mouse allergen-specific immunoglobulin G4 and risk of mouse skin test sensitivity. Clin Exp Allergy 2006;36:1097–1103.
      1. Jacobs JH, Meijster T, Meijer E, Suarthana E, Heederik D. Wheat allergen exposure and the prevalence of work-related sensitization and allergy in bakery workers. Allergy 2008;63:1597–1604.
      1. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001;357:752–756.
      1. Portengen L, de Meer G, Doekes G, Heederik D. Immunoglobulin G4 antibodies to rat urinary allergens, sensitization and symptomatic allergy in laboratory animal workers. Clin Exp Allergy 2004;34:1243–1250.
      1. Hur GY, Koh DH, Kim HA, Park HJ, Ye YM, Kim KS, Park HS. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir Med 2008;102:548–555.
      1. Nieuwenhuijsen MJ, Putcha V, Gordon S, Heederik D, Venables KM, Cullinan P, Newman-Taylor AJ. Exposure-response relations among laboratory animal workers exposed to rats. Occup Environ Med 2003;60:104–108.
      1. Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med 1999;160:435–438.
      1. Hollander A, Heederik D, Doekes G. Respiratory allergy to rats: exposure-response relationships in laboratory animal workers. Am J Respir Crit Care Med 1997;155:562–567.
      1. Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, McDonald JC, Taylor AJ. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 1999;13:1139–1143.
      1. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Natural history of sensitization, symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur Respir J 2001;17:904–908.
      1. Quirce S, Polo F, Figueredo E, González R, Sastre J. Occupational asthma caused by soybean flour in bakers--differences with soybean-induced epidemic asthma. Clin Exp Allergy 2000;30:839–846.
      1. Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, Shaughnessy MA, Malo JL. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J Allergy Clin Immunol 1993;91:850–861.
      1. Lemière C, Desjardins A, Cloutier Y, Drolet D, Perrault G, Cartier A, Malo JL. Occupational asthma due to formaldehyde resin dust with and without reaction to formaldehyde gas. Eur Respir J 1995;8:861–865.
      1. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, Redlich CA. Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 2004;113:1178–1184.
      1. Ye YM, Kim CW, Kim HR, Kim HM, Suh CH, Nahm DH, Park HS, Redlich CA, Wisnewski AV. Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J Allergy Clin Immunol 2006;118:885–891.
      1. Herrick CA, Xu L, Wisnewski AV, Das J, Redlich CA, Bottomly K. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 2002;109:873–878.
      1. Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, Hoet PH. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci 2004;80:310–321.
      1. Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol 2006;117:1090–1097.
      1. Bello D, Herrick CA, Smith TJ, Woskie SR, Streicher RP, Cullen MR, Liu Y, Redlich CA. Skin exposure to isocyanates: reasons for concern. Environ Health Perspect 2007;115:328–335.
      1. Bernstein JA, Alexis N, Bacchus H, Bernstein IL, Fritz P, Horner E, Li N, Mason S, Nel A, Oullette J, Reijula K, Reponen T, Seltzer J, Smith A, Tarlo SM. The health effects of non-industrial indoor air pollution. J Allergy Clin Immunol 2008;121:585–591.
      1. Siracusa A, Marabini A, Folletti I, Moscato G. Smoking and occupational asthma. Clin Exp Allergy 2006;36:577–584.
      1. Venables KM, Upton JL, Hawkins ER, Tee RD, Longbottom JL, Newman Taylor AJ. Smoking, atopy, and laboratory animal allergy. Br J Ind Med 1988;45:667–671.
      1. Douglas JD, McSharry C, Blaikie L, Morrow T, Miles S, Franklin D. Occupational asthma caused by automated salmon processing. Lancet 1995;346:737–740.
      1. Fuortes LJ, Weih L, Pomrehn P, Thorne PS, Jones M, Burmeister L, Merchant JA. Prospective epidemiologic evaluation of laboratory animal allergy among university employees. Am J Ind Med 1997;32:665–669.
      1. Johnsen CR, Sorensen TB, Ingemann Larsen A, Bertelsen Secher A, Andreasen E, Kofoed GS, Fredslund Nielsen L, Gyntelberg F. Allergy risk in an enzyme producing plant: a retrospective follow up study. Occup Environ Med 1997;54:671–675.
      1. Gautrin D, Cartier A, Howse D, Horth-Susin L, Jong M, Swanson M, Lehrer S, Fox G, Neis B. Occupational asthma and allergy in snow crab processing in Newfoundland and Labrador. Occup Environ Med 2010;67:17–23.
      1. Radon K. The two sides of the "endotoxin coin". Occup Environ Med 2006;63:73–78. 10.
      1. Pacheco K, Maier L, Silveira L, Goelz K, Noteware K, Luna B, du Bois R, Murphy J, Rose C. Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals. J Allergy Clin Immunol 2008;122:896–902.e4.
      1. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy 2000;30:1519–1534.
      1. Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005;62:290–299.
      1. Venables KM, Topping MD, Howe W, Luczynska CM, Hawkins R, Taylor AJ. Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br Med J (Clin Res Ed) 1985;290:201–204.
      1. Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ. Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study. Occup Environ Med 1998;55:684–691.
      1. Baker DB, Gann PH, Brooks SM, Gallagher J, Bernstein IL. Cross-sectional study of platinum salts sensitization among precious metals refinery workers. Am J Ind Med 1990;18:653–664.
      1. Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A, Artelt S, Koenig HP, Alt F, Vormberg R, Baur X, Schultze-Werninghaus G. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J Allergy Clin Immunol 2000;105:364–370.
      1. Matsui EC, Krop EJ, Diette GB, Aalberse RC, Smith AL, Eggleston PA. Mouse allergen exposure and immunologic responses: IgE-mediated mouse sensitization and mouse specific IgG and IgG4 levels. Ann Allergy Asthma Immunol 2004;93:171–178.
      1. Hollander A, Doekes G, Heederik D. Cat and dog allergy and total IgE as risk factors of laboratory animal allergy. J Allergy Clin Immunol 1996;98:545–554.
      1. Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med 2001;163:899–904.
      1. Krop EJ, Heederik DJ, Lutter R, de Meer G, Aalberse RC, Jansen HM, van der Zee JS. Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy. J Allergy Clin Immunol 2009;123:694–700.e3.
      1. Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, Mapp C, Fabbri LM, Pauli G, Lockhart A, Charron D, et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 1994;149:71–75.
      1. Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J 1996;9:207–210.
      1. Mapp CE, Beghè B, Balboni A, Zamorani G, Padoan M, Jovine L, Baricordi OR, Fabbri LM. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy 2000;30:651–656.
      1. Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995;151:219–221.
      1. Jones MG, Nielsen J, Welch J, Harris J, Welinder H, Bensryd I, Skerfving S, Welsh K, Venables KM, Taylor AN. Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acid anhydrides. Clin Exp Allergy 2004;34:812–816.
      1. Horne C, Quintana PJ, Keown PA, Dimich-Ward H, Chan-Yeung M. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur Respir J 2000;15:911–914.
      1. Rihs HP, Chen Z, Ruëff F, Cremer R, Raulf-Heimsoth M, Baur X, Moneret-Vautrin DA, Brüning T. HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy. J Allergy Clin Immunol 2002;110:507–514.
      1. Jeal H, Draper A, Jones M, Harris J, Welsh K, Taylor AN, Cullinan P. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies? J Allergy Clin Immunol 2003;111:795–799.
      1. Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int Arch Allergy Immunol 2009;150:156–163.
      1. Rihs HP, Barbalho-Krölls T, Huber H, Baur X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am J Ind Med 1997;32:522–527.
      1. Bernstein JA, Munson J, Lummus ZL, Balakrishnan K, Leikauf G. T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma. J Allergy Clin Immunol 1997;99:245–250.
      1. Beghe B, Padoan M, Moss CT, Barton SJ, Holloway JW, Holgate ST, Howell WM, Mapp CE. Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy 2004;59:61–64.
      1. Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, Boulet LP, Malo JL, Yucesoy B, Luster M, Tarlo SM, Hershey GK. Diisocyanate asthma and gene-environment interactions with IL-4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol 2006;97:800–806.
      1. Wisnewski AV, Liu Q, Liu J, Redlich CA. Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates. Clin Exp Allergy 2008;38:957–967.
      1. Ye YM, Kang YM, Kim SH, Kim CW, Kim HR, Hong CS, Park CS, Kim HM, Nahm DH, Park HS. Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma. Clin Exp Allergy 2006;36:1153–1160.
      1. Piirilä P, Wikman H, Luukkonen R, Kääriä K, Rosenberg C, Nordman H, Norppa H, Vainio H, Hirvonen A. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001;11:437–445.
      1. Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002;12:227–233.
      1. Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M, Boschetto P, Strange RC, Hemmingsen A, Spiteri MA. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 2002;109:867–872.
      1. Berode M, Jost M, Ruegger M, Savolainen H. Host factors in occupational diisocyanate asthma: a Swiss longitudinal study. Int Arch Occup Environ Health 2005;78:158–163.
      1. Kim SH, Cho BY, Park CS, Shin ES, Cho EY, Yang EM, Kim CW, Hong CS, Lee JE, Park HS. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy 2009;39:203–212.
      1. Mapp CE. What is the role of genetics in occupational asthma? Eur Respir J 2009;33:459–460.
      1. Gautrin D, Ghezzo H, Infante-Rivard C, Magnan M, L'Archevêque J, Suarthana E, Malo JL. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents. Am J Respir Crit Care Med 2008;177:871–879.
      1. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301–304.
      1. Boutet K, Malo JL, Ghezzo H, Gautrin D. Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax 2007;62:260–264.
      1. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, Wjst M, Cerveri I, Pin I, Bousquet J, Jarvis D, Burney PG, Neukirch F, Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049–1057.
      1. Vandenplas O, Van Brussel P, D'Alpaos V, Wattiez M, Jamart J, Thimpont J. Rhinitis in subjects with work-exacerbated asthma. Respir Med 2010;104:497–503.
      1. Karjalainen A, Martikainen R, Klaukka T, Saarinen K, Uitti J. Risk of asthma among Finnish patients with occupational rhinitis. Chest 2003;123:283–288.
      1. Elliott L, Heederik D, Marshall S, Peden D, Loomis D. Progression of self-reported symptoms in laboratory animal allergy. J Allergy Clin Immunol 2005;116:127–132.
      1. Moscato G, Vandenplas O, Gerth Van Wijk R, Malo JL, Quirce S, Walusiak J, Castano R, De Groot H, Folletti I, Gautrin D, Yacoub MR, Perfetti L, Siracusa A. Occupational rhinitis. Allergy 2008;63:969–980.
      1. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Host determinants for the development of allergy in apprentices exposed to laboratory animals. Eur Respir J 2002;19:96–103.
      1. Howse D, Gautrin D, Neis B, Cartier A, Horth-Susin L, Jong M, Swanson MC. Gender and snow crab occupational asthma in Newfoundland and Labrador, Canada. Environ Res 2006;101:163–174.
    Cited by
    Crossref 79
    Google Scholar 
    PubMed Central 35
    Scopus 83
    Web of Science 79
    MeSH Terms
    Alleles
    Asthma
    Asthma, Occupational
    Gene-Environment Interaction
    Genetic Predisposition to Disease
    Hypersensitivity
    Leukocytes
    Occupational Diseases
    Primary Prevention
    Risk Factors
    Smoke
    Structure-Activity Relationship
    Tobacco Products
    Metrics
    Share
    Links to
    Tables
    slide
    slide

    1 / 2

    Funding Information
    PERMALINK